4Kaufman DS. Toward clinical therapies using hematopoietic cells derived from human pluripotent stem cells. Blood, 2009, 114 ( 17 ) :3513-3523.
5Muller R, Lengerke C. Patient-specific plufipotent stem cells: promises and challenges. Nat Rev Endocfinol, 2009,5(4) :195- 203.
6Fujita Y, Rooney CM, Heslop HE. Adoptive cellular immunotherapy for viral diseases. Bone Marrow Transplant, 2008, 41 (2) :193-198.
7Templin C, Kotlarz D, Faulhaber J, et al. Ex vivo expanded hematopoietic progenitor cells improve cardiac function after myocardial infarction : role of beta-catenin transduetion and cell dose. J Mol Cell Cardiol, 2008, 45(3) :394-403.
8Freimark D, Czermak P. CelL-based regeneration of intervertebral disc defects : review and concepts. Int J Artif Organs, 2009, 32 (4) :197-203.
9Giordano A, Galderisi U, Marino IR. From the laboratory bench to the patient' s bedside: An update on clinical trials with mesenchymal stem cells. J Cell Physiol, 2007, 211(I) :27-35.
10Chamberlain G, Fox J, Ashton B, Middleton J. Concise review: Mesenchymal stem cells: Their phenotype, differentiation capacity, immunological features and potential for homing. Stem Cells, 2007, 25:2739-2749.
二级参考文献51
1Wang S,Hong S,Wezeman M,et al.Dendritic cell vaccine but not idiotype-KLH protein vaccine primes therapeutic tumor-specific immunity against multiple myeloma.Front Biosci,2007, 12:3566-3575
2Van de-Velde AL,Berneman ZN,Van Tendeloo VF.Immunotherapy of hematological malignancies using dendritic cells.Bull Cancer,2008, 95:320-326
3Hundemer M,Schmidt S,Condomines M,et al.Identification of a new HLA-A2-restricted T-cell epitope within HM1.24 as immunotherapy target for multiple myeloma.Exp Hematol,2006,34:486-496
4Rew SB,Peggs K,Sanjuan I,et al.Generation of potent antitumor CTL from patients with multiple myeloma directed against HM1.24.Clin Cancer Res,2005 , 11:3377-3384
5Qian J,Xie J,Hong S,et al.Dickkopf-1 (DKK1) is a widely expressed and potent tumor-associated antigen in multiple myeloma.Blood,2007, 110:1587-1594
6Dadabayev AR,Wang Z,Zhang Y,et al.Cancer immunotherapy targeting Sp17:when should the laboratory findings be translated to the clinics? Am J Hematol,2005 , 80:6-11
7Lee JJ,Choi BH,Kang HK,et al.Induction of multiple myeloma-specific cytotoxic T lymphocyte stimulation by dendritic cell pulsing with purified and optimized myeloma cell lysates.Leuk Lymphoma,2007 , 48:2022-2031
8Hayashi T,Hideshima T,Akiyama M,et al.Ex vivo induction of multiple myeloma-specific cytotoxic T lymphocytes.Blood,2003 ,102:1435-1442
9Vasir B,Borges V,Wu Z,et al.Fusion of dendritic eels with multiple myeloma cells results in maturation and enhanced antigen presentation.Br J Haematol,2005 , 129:687-700
8Zhang Y, Joe G, Hexner E, et al. Host-reactive CD8 + memory stem cells in graft-versus-host disease [ J ]. Nat Med, 2005, 11 (12) : 1299-1305.
9Gattinoni L, Lugli E, Ji Y, et al. A human memory T cell subset with stem cell-like properties[J]. Nat Med, 2011, 17(10) : 1290-1297.
10Lugli E, Gattinoni L, Roberto A, et al. Identification,isolation and in vitro expansion of human and nonhuman primate T stem cell memory cells[J]. Nat Protoc, 2013, 8 ( 1 ) :33-42.
